Clinical Trial Update: A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

View source ↗

Summary

This clinical trial update describes the use of DARWEN, an artificial intelligence technology, for eye disorders. It investigates factors influencing treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Snippet

Sponsor: Bayer | Conditions: Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion | Status: COMPLETED